External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Inflammatory Disease ECCO 2026
Roche and Genentech at

ECCO 2026

February 18 - February 21
Stockholm, Sweden
ecco-ibd.eu/ecco26
We will be contributing to topics related to
Inflammatory Disease
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
11:40 AM
Duration 60mins Stockholm, Sweden
Functional Advantage of Afimkibart’s Preference for Trimeric TL1A in Blocking Active TL1A Signaling
Domagoj Vucic
Inflammatory Disease | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Stockholm, Sweden
Indirect Comparison of Afimkibart and Adalimumab Treatment Effects in Patients With Ulcerative Colitis Using Data From TUSCANY-2 and HIBISCUS
Steven Levitte
Inflammatory Disease | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Stockholm, Sweden
Afimkibart Fully Neutralizes TL1A Activity, Rendering DcR3–TL1A Blockade Biologically Inconsequential
Vishnu Mohanan
Inflammatory Disease | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Stockholm, Sweden
Afimkibart Downregulates Th17, Myeloid and Fibrotic Pathways in Ulcerative Colitis: Serum Proteomics From the Phase 2b TUSCANY-2 Trial
Margaret Neighbors
Inflammatory Disease | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Stockholm, Sweden
Understanding the Clinical Trial Experience of People Living With Inflammatory Bowel Disease (IBD), and Identifying Unmet Needs and Key Challenges That Impact Trial Participation
Roberto Saldaña
Inflammatory Disease | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.